4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-[2-(2-methyl-4-oxo-6,7,8,9-tetra-hydro-4H-pyrido[1,2-a]pyrimidin-3-yl)eth-yl]piperidinium nitrate.

ABSTRACT: In the risperidone cation of the title compound, C(23)H(28)FN(4)O(2) (+)·NO(3) (-), the piperidine ring adopts a chair conformation and the tetra-hydro-pyridine ring is disordered over two orientations in a 0.620 (11):0.380 (11) ratio. N-H⋯O, C-H⋯O and C-H⋯F hydrogen bonds are present in the crystal structure.

SUBMITTER: Sun Y 

PROVIDER: S-EPMC2969342 | biostudies-literature | 2009 Jun

REPOSITORIES: biostudies-literature